Cell Line

hPSCreg name ITXi001-A
Cite as:
Alternative name(s)
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
(GPR146KO Cl2)
Last update 27th January 2023
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.


Generator l’institut du thorax (ITX)
Owner l’institut du thorax (ITX)
Derivation country France

External Databases

BioSamples SAMEA10368003
Cellosaurus CVCL_B5IP
Wikidata Q110432989

General Information

* Is the cell line readily obtainable for third parties?

Donor Information

General Donor Information

Sex female
Ethnicity Caucasienne

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.
Disease associated phenotypes no phenotypes

Karyotyping (Donor)

Has the donor karyotype been analysed?

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?

External Databases (Donor)

BioSamples SAMEA10367957


Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Provide contact information of the holder of the original Donor Information Sheet: amandine.caillaud@univ-nantes.fr
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Alternatives to consent are available? No
Is there other documentation provided to the donor for consenting purposes? No
Confirm that consent was obtained by a qualified professional Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. anonymised
Does consent explicitly allow the derivation of pluripotent stem cells? No
Does the consent permit uses of donated embryo/tissue or derived cell line intended for clinical treatment or human applications? No
Does consent expressly prevent development of commercial products? No
Does consent expressly prevent financial gain from any use of the donated embryo/tissue, including any product made from it? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? No information
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? French Ministry of Health
Approval number DC-2011-1399
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation


Source cell type
An excreta material which is composed primarily of urine, a liquid excreta containing water and waste products made by the kidneys, stored in the bladder, and leaves the body through the urethra.; ENVO bodily fluid classes differ from UBERON's treatment of bodily fluids. UBERON refers to the substance itself ("S"). We assert that UBERON's classes are the primary compositional component of the terms in ENVO ("S material"). Use of the ENVO terms is typically recommended when you wish to indicate that there may be other materials intermixed with S.
Source cell origin
The fluid that is excreted by the kidneys. It is stored in the bladder and discharged through the urethra.
  • Urine
  • Urinary System, Urine
  • urine
show more synonyms

Reprogramming method

Vector type Non-integrating
Vector Episomal
Methods used

Vector free reprogramming


Derived under xeno-free conditions
Derived under GMP?
Available as clinical grade?

Culture Conditions

Surface coating Matrigel/Geltrex
Passage method Enzyme-free cell dissociation
Gentle Cell Dissociation Reagent
O2 Concentration 4 %
CO2 Concentration 5 %
Medium Other medium:
Base medium: StemMACS iPS-Brew medium
Main protein source:
Serum concentration: %
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?


Analysis of Undifferentiated Cells
Morphology pictures
By Immunofluorescence staining : positive for OCT3/4 and Tra1-60 By flow cytometry analysis : positive at SSEA4, SSEA3 and TRA1-60
Method documentation
Capture d’écran 2021-11-23 à 14.40.48.png
Immunofluorescence staining for Pluripotency markers : OCT3/4 (green), TRA1-60 (red) and DAP (blue)
Capture d’écran 2021-11-23 à 14.44.21.png
Results of flow cytometry analysis for Pluripotency markers SSEA4, SSEA3, TRA1-60
Differentiation Potency
Ont Id: UBERON_0000925
In vivo teratoma
Ont Id: UBERON_0000926
In vivo teratoma
Ont Id: UBERON_0000924

Microbiology / Virus Screening

Mycoplasma Negative


Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Normal karyotype of hERG CT Cl9 cell line

Other Genotyping (Cell Line)